Sandra A Springer

Dados Biográficos

ID	4860768
NOME	Sandra A Springer
PRENOMES	Sandra A
SOBRENOME	Springer
ASSINATURA	SPRINGER S A
AFILIAÇÕES	Yale University
ORCID	0000-0002-6318-1000
VERIFICADO	Sim
TOTAL DE OBRAS	21
TOTAL DE CITAÇÕES	9
TOTAL COMO AUTOR	21
TOTAL COMO EDITOR	0
PRIMEIRO ANO DE PUBLICAÇÃO	2004
ANO MAIS RECENTE DE PUBLICAÇÃO	2025
ÍNDICE H	2

A qualitative examination of barriers and facilitators to HIV prevention and treatment for people involved with the criminal justice system
Open AccessStephanie Villaire, Thomas Sease et al.ARTICLEHealth & Justice2025
BACKGROUND: In an effort to address health risks for HIV among justice-involved individuals, linkage to community services for HIV and substance use disorder prevention and treatment is critical. Stakeholder feedback informing the development of interventions aimed at linking individuals to care is paramount to ensuring the success of the intervention. The current study examines focus group data collected as part of a 5-year NIDA-funded project a…
Overdose education and naloxone distribution in jails
Open AccessTimothy Hunt, Carrie B Oser et al.ARTICLEHealth & Justice2025
BACKGROUND: Opioid-related overdose is the leading cause of mortality among individuals recently released from incarceration in the U.S. Naloxone is an FDA-approved opioid antagonist medication designed to rapidly reverse opioid overdose. Despite evidence of its acceptability and effectiveness at reducing the risk of opioid overdose death after release from incarceration, only an estimated 25% of US jails provide naloxone upon release. This study…
The impact of Covid-19 on the treatment of opioid use disorder in carceral facilities
Open AccessElizabeth C Saunders, Milan F Satcher et al.ARTICLEHealth & Justice2022
While the COVID-19 pandemic disrupted healthcare delivery everywhere, persons with carceral system involvement and opioid use disorder (OUD) were disproportionately impacted and vulnerable to severe COVID-associated illness. Carceral settings and community treatment programs (CTPs) rapidly developed protocols to sustain healthcare delivery while reducing risk of COVID-19 transmission. This survey study assessed changes to OUD treatment, telemedic…
Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community
Open AccessNoor Taweh, Esther Schlossberg et al.ARTICLEInternational Journal of Drug…2021
Hepatitis C in the United States
Carlos Del Rio, Sandra A SpringerARTICLEAmerican Journal of Public Health2021Referências: 7
Hepatitis C in the United States: One Step Forward, Two Steps Back Carlos del Rio MD, and Sandra A. Springer MD Affiliation Carlos del Rio, MD, is with the Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine and the Grady Health System, Atlanta, GA. Sandra A. Springer, MD, is with the Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT.CopyRightCorrespondence shou…
Our legends and journey stories
Tracey T Flores, Sandra Springer et al.ARTICLETheory Into Practice2021Citada por: 7Referências: 18
Humanizing family engagement practices seek to foster the community cultural wealth and funds of knowledge to working with and for immigrant families and communities. In this manuscript we explore asset-based theories for working alongside families and communities in our schools, with a focus on classroom examples for involving parents and families in school learning. We share the ways that teachers and schools can build curriculum and engagement…
Co-calibration of two self-reported measures of adherence to antiretroviral therapy
Robin M Nance, Joseph Delaney et al.ARTICLEAIDS Care2017
Adherence to antiretroviral therapy (ART) is an important determinant of clinical success assessed in many HIV studies. Harmonizing adherence data from studies that use different measures is difficult without a co-calibration equation to convert between validated instruments. Our purpose was to co-calibrate two commonly used adherence measures: the AIDS Clinical Trials Group (ACTG) questionnaire and the Visual Analog Scale (VAS). We used robust l…
Gender Differences in HIV Risk Behaviors Among Persons Involved in the U.S. Criminal Justice System and Living with HIV or at Risk for HIV
Open AccessKelsey B Loeliger, Mary L Biggs et al.ARTICLEAIDS and Behavior2017
HIV-infected men who have sex with men, before and after release from jail
Panagiotis Vagenas, Alexei Zelenev et al.ARTICLEAIDS Care2016
The US HIV/AIDS epidemic is concentrated among men who have sex with men (MSM). Black men are disproportionately affected by incarceration and Black MSM experience higher infection rates and worse HIV-related health outcomes compared to non-Black MSM. We compared HIV treatment outcomes for Black MSM to other HIV-infected men from one of the largest cohorts of HIV-infected jail detainees (N = 1270) transitioning to the community. Of the 574 HIV-in…
The Impact of Alcohol Use and Related Disorders on the HIV Continuum of Care: a Systematic Review
Open AccessPanagiotis Vagenas, Marwan M Azar et al.ARTICLECurrent HIV/AIDS Reports2015
A comparison of psychiatric diagnoses among HIV-infected prisoners receiving combination antiretroviral therapy and transitioning to the community
Open AccessAngela Di Paola, Frederick L Altice et al.ARTICLEHealth & Justice2014
BACKGROUND: The criminal justice system (CJS), specifically prisons and jails, is ideally suited for uniform screening of psychiatric (PD) and substance use disorders (SUDs) among people living with HIV/AIDS (PLWHA), who are concentrated in these settings. By accurately diagnosing PDs and SUDs in these controlled settings, treatment can be initiated and contribute to improved continuity of care upon release. In the context of PLWHA, it may also i…
Contribution of Substance Use Disorders on HIV Treatment Outcomes and Antiretroviral Medication Adherence Among HIV-Infected Persons Entering Jail
Open AccessEhsan Chitsaz, Jaimie P Meyer et al.ARTICLEAIDS and Behavior2013
The Impact of DSM-IV Mental Disorders on Adherence to Combination Antiretroviral Therapy Among Adult Persons Living with HIV/Aids
Sandra A Springer, Azem Dushaj et al.ARTICLEAIDS and Behavior2012
Post-Release Substance Abuse Outcomes Among HIV-Infected Jail Detainees
Open AccessArchana Krishnan, Jeffrey A Wickersham et al.ARTICLEAIDS and Behavior2012
Substance Abuse, Violence, and HIV in Women
Open AccessJaimie P Meyer, Sandra A Springer et al.ARTICLEJournal of women's health2011
Women in the United States are increasingly affected by HIV/AIDS. The SAVA syndemic—synergistic epidemics of substance abuse, violence, and HIV/AIDS—is highly prevalent among impoverished urban women and potentially associated with poor HIV outcomes. A review of the existing literature found 45 articles that examine SAVA's impact on (1) HIV-associated risk-taking behaviors, (2) mental health, (3) healthcare utilization and medication adherence, a…
Adherence to HIV Treatment and Care Among Previously Homeless Jail Detainees
Open AccessNadine E Chen, Jaimie P Meyer et al.ARTICLEAIDS and Behavior2011
A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization
Open AccessMarwan M Azar, Sandra A Springer et al.ARTICLEDrug and Alcohol Dependence2010
Improved HIV and Substance Abuse Treatment Outcomes for Released HIV-Infected Prisoners
Open AccessSandra A Springer, Shu Chen et al.ARTICLEJournal of Urban Health2010Citada por: 2Referências: 1
HIV-infected prisoners fare poorly after release. Though rarely available, opioid agonist therapy (OAT) may be one way to improve HIV and substance abuse treatment outcomes after release. Of the 69 HIV-infected prisoners enrolled in a randomized controlled trial of directly administered antiretroviral therapy, 48 (70%) met DSM-IV criteria for opioid dependence. Of these, 30 (62.5%) selected OAT, either as methadone (N = 7, 14.5%) or buprenorphine…
Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy
Sandra A Springer, Shu Chen et al.ARTICLEAIDS Care2009
BACKGROUND: Depression is highly prevalent among HIV-infected injection drug users (IDUs) and has been associated with poor adherence to antiretroviral therapy and increased morbidity and mortality. Factors associated with changes in depressive symptoms among this group receiving antiretroviral treatment that have not been extensively evaluated. METHODS: This post-hoc analysis of prospective clinical trial analyzes the factors associated with cha…
Initiation, Adherence, and Retention in a Randomized Controlled Trial of Directly Administered Antiretroviral Therapy
Open AccessDuncan Maru, Duncan SMITH-ROHRBERG Maru et al.ARTICLEAIDS and Behavior2007
Effectiveness of Antiretroviral Therapy among HIV-Infected Prisoners
Sandra A Springer, E Pesanti et al.ARTICLEClinical Infectious Diseases2004
Responses to highly active antiretroviral therapy (HAART) in correctional settings and their sustained benefit in prisoners after release are currently not known. To examine the human immunodeficiency virus type 1 (HIV-1) RNA level (VL) and CD4 lymphocyte response to HAART during incarceration and upon reentry to the correctional system, we conducted a retrospective cohort study of longitudinally linked demographic, pharmacy, and laboratory data …

Effectiveness of Antiretroviral Therapy among HIV-Infected Prisoners
Sandra A Springer, E Pesanti et al.ARTICLEClinical Infectious Diseases2004
Responses to highly active antiretroviral therapy (HAART) in correctional settings and their sustained benefit in prisoners after release are currently not known. To examine the human immunodeficiency virus type 1 (HIV-1) RNA level (VL) and CD4 lymphocyte response to HAART during incarceration and upon reentry to the correctional system, we conducted a retrospective cohort study of longitudinally linked demographic, pharmacy, and laboratory data …
Initiation, Adherence, and Retention in a Randomized Controlled Trial of Directly Administered Antiretroviral Therapy
Open AccessDuncan Maru, Duncan SMITH-ROHRBERG Maru et al.ARTICLEAIDS and Behavior2007
Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy
Sandra A Springer, Shu Chen et al.ARTICLEAIDS Care2009
BACKGROUND: Depression is highly prevalent among HIV-infected injection drug users (IDUs) and has been associated with poor adherence to antiretroviral therapy and increased morbidity and mortality. Factors associated with changes in depressive symptoms among this group receiving antiretroviral treatment that have not been extensively evaluated. METHODS: This post-hoc analysis of prospective clinical trial analyzes the factors associated with cha…
A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization
Open AccessMarwan M Azar, Sandra A Springer et al.ARTICLEDrug and Alcohol Dependence2010
Improved HIV and Substance Abuse Treatment Outcomes for Released HIV-Infected Prisoners
Open AccessSandra A Springer, Shu Chen et al.ARTICLEJournal of Urban Health2010Citada por: 2Referências: 1
HIV-infected prisoners fare poorly after release. Though rarely available, opioid agonist therapy (OAT) may be one way to improve HIV and substance abuse treatment outcomes after release. Of the 69 HIV-infected prisoners enrolled in a randomized controlled trial of directly administered antiretroviral therapy, 48 (70%) met DSM-IV criteria for opioid dependence. Of these, 30 (62.5%) selected OAT, either as methadone (N = 7, 14.5%) or buprenorphine…
Substance Abuse, Violence, and HIV in Women
Open AccessJaimie P Meyer, Sandra A Springer et al.ARTICLEJournal of women's health2011
Women in the United States are increasingly affected by HIV/AIDS. The SAVA syndemic—synergistic epidemics of substance abuse, violence, and HIV/AIDS—is highly prevalent among impoverished urban women and potentially associated with poor HIV outcomes. A review of the existing literature found 45 articles that examine SAVA's impact on (1) HIV-associated risk-taking behaviors, (2) mental health, (3) healthcare utilization and medication adherence, a…
Adherence to HIV Treatment and Care Among Previously Homeless Jail Detainees
Open AccessNadine E Chen, Jaimie P Meyer et al.ARTICLEAIDS and Behavior2011
The Impact of DSM-IV Mental Disorders on Adherence to Combination Antiretroviral Therapy Among Adult Persons Living with HIV/Aids
Sandra A Springer, Azem Dushaj et al.ARTICLEAIDS and Behavior2012
Post-Release Substance Abuse Outcomes Among HIV-Infected Jail Detainees
Open AccessArchana Krishnan, Jeffrey A Wickersham et al.ARTICLEAIDS and Behavior2012
Contribution of Substance Use Disorders on HIV Treatment Outcomes and Antiretroviral Medication Adherence Among HIV-Infected Persons Entering Jail
Open AccessEhsan Chitsaz, Jaimie P Meyer et al.ARTICLEAIDS and Behavior2013
A comparison of psychiatric diagnoses among HIV-infected prisoners receiving combination antiretroviral therapy and transitioning to the community
Open AccessAngela Di Paola, Frederick L Altice et al.ARTICLEHealth & Justice2014
BACKGROUND: The criminal justice system (CJS), specifically prisons and jails, is ideally suited for uniform screening of psychiatric (PD) and substance use disorders (SUDs) among people living with HIV/AIDS (PLWHA), who are concentrated in these settings. By accurately diagnosing PDs and SUDs in these controlled settings, treatment can be initiated and contribute to improved continuity of care upon release. In the context of PLWHA, it may also i…
The Impact of Alcohol Use and Related Disorders on the HIV Continuum of Care: a Systematic Review
Open AccessPanagiotis Vagenas, Marwan M Azar et al.ARTICLECurrent HIV/AIDS Reports2015
HIV-infected men who have sex with men, before and after release from jail
Panagiotis Vagenas, Alexei Zelenev et al.ARTICLEAIDS Care2016
The US HIV/AIDS epidemic is concentrated among men who have sex with men (MSM). Black men are disproportionately affected by incarceration and Black MSM experience higher infection rates and worse HIV-related health outcomes compared to non-Black MSM. We compared HIV treatment outcomes for Black MSM to other HIV-infected men from one of the largest cohorts of HIV-infected jail detainees (N = 1270) transitioning to the community. Of the 574 HIV-in…
Co-calibration of two self-reported measures of adherence to antiretroviral therapy
Robin M Nance, Joseph Delaney et al.ARTICLEAIDS Care2017
Adherence to antiretroviral therapy (ART) is an important determinant of clinical success assessed in many HIV studies. Harmonizing adherence data from studies that use different measures is difficult without a co-calibration equation to convert between validated instruments. Our purpose was to co-calibrate two commonly used adherence measures: the AIDS Clinical Trials Group (ACTG) questionnaire and the Visual Analog Scale (VAS). We used robust l…
Gender Differences in HIV Risk Behaviors Among Persons Involved in the U.S. Criminal Justice System and Living with HIV or at Risk for HIV
Open AccessKelsey B Loeliger, Mary L Biggs et al.ARTICLEAIDS and Behavior2017
Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community
Open AccessNoor Taweh, Esther Schlossberg et al.ARTICLEInternational Journal of Drug…2021
Hepatitis C in the United States
Carlos Del Rio, Sandra A SpringerARTICLEAmerican Journal of Public Health2021Referências: 7
Hepatitis C in the United States: One Step Forward, Two Steps Back Carlos del Rio MD, and Sandra A. Springer MD Affiliation Carlos del Rio, MD, is with the Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine and the Grady Health System, Atlanta, GA. Sandra A. Springer, MD, is with the Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT.CopyRightCorrespondence shou…
Our legends and journey stories
Tracey T Flores, Sandra Springer et al.ARTICLETheory Into Practice2021Citada por: 7Referências: 18
Humanizing family engagement practices seek to foster the community cultural wealth and funds of knowledge to working with and for immigrant families and communities. In this manuscript we explore asset-based theories for working alongside families and communities in our schools, with a focus on classroom examples for involving parents and families in school learning. We share the ways that teachers and schools can build curriculum and engagement…
The impact of Covid-19 on the treatment of opioid use disorder in carceral facilities
Open AccessElizabeth C Saunders, Milan F Satcher et al.ARTICLEHealth & Justice2022
While the COVID-19 pandemic disrupted healthcare delivery everywhere, persons with carceral system involvement and opioid use disorder (OUD) were disproportionately impacted and vulnerable to severe COVID-associated illness. Carceral settings and community treatment programs (CTPs) rapidly developed protocols to sustain healthcare delivery while reducing risk of COVID-19 transmission. This survey study assessed changes to OUD treatment, telemedic…
A qualitative examination of barriers and facilitators to HIV prevention and treatment for people involved with the criminal justice system
Open AccessStephanie Villaire, Thomas Sease et al.ARTICLEHealth & Justice2025
BACKGROUND: In an effort to address health risks for HIV among justice-involved individuals, linkage to community services for HIV and substance use disorder prevention and treatment is critical. Stakeholder feedback informing the development of interventions aimed at linking individuals to care is paramount to ensuring the success of the intervention. The current study examines focus group data collected as part of a 5-year NIDA-funded project a…
Overdose education and naloxone distribution in jails
Open AccessTimothy Hunt, Carrie B Oser et al.ARTICLEHealth & Justice2025
BACKGROUND: Opioid-related overdose is the leading cause of mortality among individuals recently released from incarceration in the U.S. Naloxone is an FDA-approved opioid antagonist medication designed to rapidly reverse opioid overdose. Despite evidence of its acceptability and effectiveness at reducing the risk of opioid overdose death after release from incarceration, only an estimated 25% of US jails provide naloxone upon release. This study…